AI Verdict
Both stocks have similar AI ratings. Review detailed metrics below.
WGRX vs SKYE Fundamental Comparison
| Metric | WGRX | SKYE |
|---|---|---|
| Revenue | $23.3M | N/A |
| Net Income | $-101.3M | $-55.9M |
| Net Margin | -433.9% | N/A |
| ROE | N/A | -279.3% |
| ROA | -332.5% | -197.5% |
| Current Ratio | 0.09x | 3.30x |
| Debt/Equity | N/A | 0.00x |
| EPS | $-1.43 | $-1.41 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
WGRX vs SKYE: Frequently Asked Questions
Is WGRX or SKYE a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. WGRX is rated STRONG SELL (97% confidence) while SKYE is rated STRONG SELL (97% confidence). This is not investment advice.
How does WGRX compare to SKYE fundamentally?
Wellgistics Health, Inc. has ROE of N/A vs Skye Bioscience, Inc.'s -279.3%. Net margins are -433.9% vs N/A respectively.
Which stock pays higher dividends, WGRX or SKYE?
WGRX has a dividend yield of N/A or no dividend while SKYE has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in WGRX or SKYE for long term?
For long-term investing, consider that WGRX has STRONG SELL rating with 97% confidence, while SKYE has STRONG SELL rating with 97% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about WGRX vs SKYE?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For WGRX vs SKYE, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.